Medication info
Lipstar Plus Tablet 10/5 mg (Ezetimibe, Rosuvastatin Calcium)

Lipstar Plus Tablet 10/5 mg (Ezetimibe, Rosuvastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletRosuvastatin Calcium›5.2mg / 1 tablet
Manufacturer / importer
Korea Abbott (Co., Ltd.)
Appearance
White oval film-coated tablet
Packaging
30 tablets (10 tablets x 3)/Alu-Alu
Approval status
Active

MFDS item code 201708321 · Approved 2017.12.12 · Insurance code 644206460

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine is administered once daily, with or without food. Patients should continue a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment with this medicine or adjusting the dose, blood lipid levels should be checked at intervals of 4 weeks or more, and the dose adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Korea Abbott (Co., Ltd.)

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • familial heterozygous hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B
  • elevated triglycerides
  • elevated non-HDL cholesterol
  • decreased HDL cholesterol
  • increased risk of atherosclerotic vascular diseases
  • dyslipidemia
View approved original text

This medication is used as an adjunct to diet to lower blood levels of total cholesterol, LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol, and to increase HDL cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia. For patients at high risk for atherosclerotic vascular disease due to hypercholesterolemia, it must be administered in conjunction with dietary measures and used when non-pharmacological treatments are insufficient. Before administering this drug, secondary causes such as diabetes, hypothyroidism, and chronic renal failure must be assessed and treated if necessary. During treatment, lipid tests including total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides should be conducted, especially when triglyceride levels are high, accurate LDL cholesterol measurements should be obtained. Furthermore, in the event of acute coronary incidents, lipid testing at the time of hospitalization should inform the treatment plan. Thus, this medication helps lower the risk of cardiovascular disease by improving cholesterol and lipid levels.

How to take

Adult dose

This medicine is administered once daily, with or without food. Patients should continue a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment with this medicine or adjusting the dose, blood lipid levels should be checked at intervals of 4 weeks or more, and the dose adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This drug may cause rhabdomyolysis, a rare side effect that can lead to muscle damage, and acute renal failure; therefore, patients experiencing severe muscle pain or weakness should immediately inform their doctor and discontinue treatment. This drug should not be used in patients with allergies to the active ingredients or components, those with liver disease or unexplained persistent increases in liver enzymes, those with muscle disorders, patients taking certain immunosuppressants, patients with severe renal impairment, pregnant women or women who may become pregnant, and nursing mothers. In particular, high doses of this drug are contraindicated in patients at risk for muscle disorders, such as those with moderate to severe kidney dysfunction, hypothyroidism, family history of muscle disorders, history of muscle side effects with other statins or fibrates, alcoholics, and Asian patients; caution is required. Patients taking this drug should have regular liver function tests, and if symptoms of liver damage or persistently elevated liver enzymes occur, dose adjustment or discontinuation may be necessary. If symptoms like muscle pain, cramps, and weakness occur, consult a doctor immediately and check for muscle damage through blood tests, and discontinue treatment in severe cases. This drug may interact with other medications; therefore, caution is needed, especially when used with anticoagulants, fibrate drugs, certain antibiotics, antifungals, immunosuppressants, etc., and patients should inform their doctor or pharmacist of any medications they are taking. Pregnant or nursing women should not take this medicine, and fertile women should use appropriate contraception. Elderly patients or those with impaired renal function have a higher risk of muscle damage, hence they need more careful monitoring during medication. This drug has not been established as safe or effective in children and is not recommended. In case of overdose, there is no specific antidote; hence treatment should be symptom-based, and liver function and muscle enzyme tests should monitor the patient's condition. Store this drug out of reach of children and do not transfer it to another container.

Side effects

Increased ALT, Increased AST, Gastroesophageal reflux disease, Dizziness, Pruritus, Increased CPK, Sensory loss, Back pain, Neurogenic bladder, Nasopharyngitis, Upper respiratory infection, Colon polyp, Headache, Angioedema, Diabetes, Headache, Constipation, Nausea, Abdominal pain, Pancreatitis, Itching, Rash, Urticaria, Myalgia, Myopathy, Rhabdomyolysis, Weakness, Thrombocytopenia, Jaundice, Hepatitis, Toxic hepatitis, Stevens-Johnson syndrome, Eosinophilia with systemic symptoms drug reaction syndrome, Lupus-like syndrome, Muscle rupture, Arthralgia, Immune-mediated necrotizing myopathy, Hematuria, Edema, Depression, Sleep disturbances, Interstitial lung disease, Sexual dysfunction, Gynecomastia, Cognitive impairment, Headache, Chest pain, Cough, Myalgia, Increased CK, Constipation, Weakness, Joint pain, Fatigue, Numbness, Sensory abnormalities, Chest discomfort, Anorexia, Abdominal distension, Abnormal liver function tests, Syncope, Generalized pain, Muscle cramps, Gout, Erectile dysfunction, Fatigue, Abdominal pain, Diarrhea, Viral infection, Pharyngitis, Sinusitis, Cough, Anaphylaxis, Urticaria, Rash, Angioedema, Erythema multiforme, Cholelithiasis, Cholecystitis, Somnolence, Neurodegenerative disorders, Positional dizziness, Migraine, Bronchitis, Rhinitis, Cystitis, Onychomycosis, Soft tissue infection, Hepatic steatosis, Liver impairment, Hepatotoxicity, Acute hepatitis, Increased gamma-glutamyl transferase, Increased blood cholesterol, Increased blood alkaline phosphatase, Irregular heart rate, Osteoarthritis, Osteoporosis, Musculoskeletal stiffness, Musculoskeletal discomfort, Muscle weakness, Diaphoresis, Dermatitis, Skin burning sensation, Skin disorder, Alopecia, Oropharyngeal pain, Nasal congestion, Respiratory distress, Pelvic pain, Breast cyst, Ptosis, Diabetic retinopathy, Ear discomfort, Renal dysfunction, Benign esophageal neoplasm, Acute renal failure, Oliguria, Increased serum creatinine

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is best to keep it at room temperature between 1°C and 30°C, away from extremes of temperature.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets (10 tablets x 3)/Alu-Alu

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.